Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults

NCT00314054 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C
Hepatic Insufficiency

Interventions

DRUG: HCV-796

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Collaborators

[object Object]